Conexeu Sciences completes $5 million private placement
Conexeu Sciences Inc. closed a private placement of approximately $5 million, issuing 1,666,667 units at $3.00 each. Each unit contains one common share and one warrant, with a $250,000 portion held in escrow pending stockholder approval. The proceeds will fund working capital, manufacturing scale‑up, regulatory testing and preclinical work for its planned FDA 510(k) submission for Ten Minute Tissue in the first quarter of 2027.
Why it matters
The capital raise provides cash to advance the company’s lead wound‑care device toward a regulatory filing, extending its runway. The escrowed $250,000 could be returned if shareholders do not approve, affecting the final amount of usable funds.
Key facts
- 1The private placement raised approximately $5 million. tradingview.com
- 21,666,667 units were sold at $3.00 per unit. investing.com
- 3$250,000 of subscriptions from management and directors are held in escrow pending stockholder approval. saultstar.com
- 4Each unit includes one share of common stock and one warrant exercisable at $3.00 for 24 months. medicalbuyer.co.in
- 5Proceeds will be used for working capital, manufacturing scale‑up, regulatory testing and preclinical work for a planned FDA 510(k) submission in Q1 2027. investing.com
- 6No placement agent was engaged and no commissions were paid. saultstar.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.